Indranil Dey, President and CEO, 10% Owner at Bluejay Diagnostics, Inc. (BJDX), bought 500 shares at $3.27 ($2K) on 2023-12-13, disclosed to the SEC on 2023-12-14.
Open-market purchase of $2k BJDX by President and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.